The SIOPEN Executive Committee
Featured
Lucas Moreno is a paediatric oncologist dedicated to early phase clinical trials and neuroblastoma. He trained in La Fe (Valencia, Spain), started his career in the Royal Marsden Hospital (London, UK) under the mentorship of Andy Pearson.
Maja Beck Popovic is Professor of pediatric hematology oncology and Head of the Pediatric Hematology Oncology Unit at the University Hospital in Lausanne, Switzerland.
Cormac is a consultant paediatric oncologist at CHI, Crumlin and associate clinical professor at University College Dublin. He is the clinical lead of the Cancer Clinical Trials Unit at CHI.
Carla has been Clinical Trials Coordinator and Manager in the Pediatric Oncology and Hematology Department at the Vall d'Hebron University Hospital since 2018.
She has coordinated more than 50 clinical trials, launched more than 10 research projects, and has developed links with SEHOP in Spain, and ITCC. She graduated in 2015 as Biologist and in 2018 with a Master’s Degree in Clinical Trials Monitoring.
A physician-scientitist originally from Heidelberg, Germany, Gudrun Schleiermacher studied medicine in Heidelberg, including a final year in the USA, and obtained her basic medical training as a pediatrician in Paris, France and Edinburgh, UK.
Loredana Amoroso is a pediatric oncologist whose main interest is neuroblastoma, and in particular early clinical trials and precision medicine.
Sabine Sarnacki is Professor of Pediatric Surgery, head of the Department of Pediatric Surgery in Necker-Enfants Malades Hospital, Paris, France. She is involved in pediatric oncology since more than 20 years with a particular interest in neuroblastoma.
Professor Jelena Rascon graduated from the Faculty of Medicine at Vilnius University in 1995. In 1998, she finished her pediatric haematology and oncology training at Vilnius University. In 2002, she established a pediatric hematopoietic stem cell transplant program in Lithuania after receiving specialised training at the Children's Bone Marrow Transplant Unit of the Charité University Medicine in Berlin.
Thorsten Simon is associate professor of pediatrics since 2011 and clinical director of the department of pediatric oncology and hematology of the University of Cologne since 2014. After training in general pediatrics, he completed his pediatric oncology/hematology training at the University of Cologne in 2006.
Sabine Taschner-Mandl, PhD, has been head of the Tumor Biology group at St. Anna Children's Cancer Research Institute (Vienna Austria) since 2018, where she has been working scientifically since 2008. Taschner-Mandl completed her studies of Molecular Biology and Genetics at the University of Vienna.
Maja Česen Mazič is a pediatric oncologist at Pediatric Oncology/Hematology Department, University Children's Hospital Ljubljana, Slovenia.
Dr Vassilios Papadakis obtained his MD degree with summa cum laude in 1986 from the University of Athens. He completed Residency in Pediatrics (1987-1990) at St Luke’s/ Roosevelt Medical Center of the Columbia University of Physicians and Surgeons and full Fellowship in Pediatric Hematology-Oncology at Memorial Sloan-Kettering Cancer Center and NYH Cornell Medical Center (1990-1993, NYC).
Dr Irene Jiménez has started her training in pediatric oncology in 2011 at the Institut Curie, in Paris. She has first worked for 5 years in the Department of Pediatric Oncology, leaded by Jean Michon.
Toby Trahair is a senior staff specialist in paediatric & haematology and oncology at the Kids Cancer Centre, Sydney Children’s Hospital, a translational researcher at the Children’s Cancer Institute and conjoint lecturer at the University of New South Wales.
She is the clinical lead of the Southampton Paediatric Oncology unit and also leads a translational research group focused on novel antibody immunotherapies for neuroblastoma, including preclinical evaluation of novel combinational therapies as well as early phase clinical trials. Her specific research interests include anti-GD2 and immunomodulatory antibodies, such as those targeting PD-1.
Dr. Annemieke Littooij is senior consultant pediatric radiology at University Medical Center Utrecht and the Princess Maxima Center for pediatric oncology in Utrecht, the Netherlands.
Leona Knox is Head of Research at Solving Kids’ Cancer UK, a non-profit organisation driving international collaboration to speed up pioneering clinical research that could improve outcomes for children.
Claudia Pasqualini is a medical doctor specialized in pediatric oncology. She is leading the HR-NBL-2 trial and is an active researcher in precision medicine.
Pablo Berlanga MD, PhD, is a paediatric oncologist at Gustave Roussy Cancer Campus, involved in early-phase pediatric clinical trials and precision medicine. He is a member of the ITCC and SIOPEN.
Ulrike is statistician at CCRI, Vienna. She is the team lead of the statistical group of the CCRI.
Professor Andy Pearson is chair of Solving Kids Cancer Scientific Advisory Board, Trustee of Neuroblastoma UK, and member of the Programme Committee of Fight Kids Cancer. He was awarded a Life Time Achievement Award from Advances in Neuroblastoma Research in 2016. Pearson’s expertise is in the fields of drug development and neuroblastoma and has over 45 years of experience in clinical paediatric oncology.
Prof. Lang is the deputy medical director of the department of Hematology/Oncology, University Children’s Hospital Tuebingen. He is a member of the American Society of Hematology, the EBMT pediatric working party, the SIOPEN group and of several German study executive boards.